Glycemia and cognitive function in metabolic syndrome and coronary heart disease

Radhika Avadhani1, Kristen Fowler1, Corinne Barbato1

  • 1Joslin Diabetes Center, Boston, Mass.

Insights

Higher hemoglobin A1c (HbA1c) is linked to poorer cognitive function in men with cardiovascular disease. These findings suggest that even slightly elevated blood sugar may impact brain health, highlighting the importance of glucose control.

Area of Science:

  • Cardiovascular Disease Research
  • Neuroscience
  • Metabolic Syndrome Studies

Background:

  • Elevated hemoglobin A1c (HbA1c) correlates with cognitive decline in type 2 diabetes.
  • The association between HbA1c and cognitive function at lower dysglycemia levels in patients with established cardiovascular disease (CVD) is not well-established.

Purpose of the Study:

  • To investigate the relationship between HbA1c levels and cognitive performance in men with metabolic syndrome and stable coronary artery disease.
  • To determine if associations between HbA1c and cognitive function persist across a spectrum of glycemic control, including normoglycemia.

Main Methods:

  • Cognitive performance was assessed using multiple tests: Mini-Mental State Examination, Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency.
  • The study included 226 men with metabolic syndrome and established coronary artery disease, with HbA1c levels analyzed in relation to cognitive test scores.
  • Statistical models adjusted for age and other cardiovascular covariates to evaluate the independent association of HbA1c with cognitive function.

Main Results:

  • Hemoglobin A1c (HbA1c) was significantly associated with performance on the Digit Symbol Substitution Test, Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency, but not the Mini-Mental State Examination.
  • In age-adjusted analyses, a 1% increase in HbA1c was linked to lower scores on the Digit Symbol Substitution Test and Rey Auditory Verbal Learning Test, and higher scores on the Trail Making Test, indicating poorer cognitive function.
  • Multivariate models confirmed HbA1c's association with Rey Auditory Verbal Learning Test, Trail Making Test, and Categorical Verbal Fluency, even after accounting for age, education, and cardiovascular factors.

Conclusions:

  • Higher HbA1c levels are associated with reduced cognitive function across several domains in men with metabolic syndrome and coronary artery disease.
  • These findings indicate that glycemic control, even within or near the normal range, may be important for maintaining cognitive health in this population.
  • Further research is warranted to explore whether interventions aimed at lowering glucose levels can improve cognitive outcomes in individuals with cardiovascular disease.
Abstract

Related Concept Videos

Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
4.4K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
8
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
9
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
21
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
23